STOCK TITAN

Camp4 Therapeutics Corp. Stock Price, News & Analysis

CAMP Nasdaq

Welcome to our dedicated page for Camp4 Therapeutics news (Ticker: CAMP), a resource for investors and traders seeking the latest updates and insights on Camp4 Therapeutics stock.

CAMP4 Therapeutics Corporation (Nasdaq: CAMP) is a clinical-stage biopharmaceutical company developing regulatory RNA-targeting therapeutics designed to upregulate gene expression and restore healthy protein levels in genetic diseases. The CAMP news feed highlights how the company advances its antisense oligonucleotide (ASO) pipeline, progresses clinical and preclinical programs, and enters strategic collaborations.

Readers can follow CAMP4’s updates on its SYNGAP1-related disorders program, including announcements about GLP toxicology studies for CMP-SYNGAP-01, translational data in humanized mouse models and non-human primates, and plans for Phase 1/2 clinical trial applications. News items also cover the company’s Urea Cycle Disorders program and the CMP-CPS-001 (CMP-001) Phase 1 trial, where CAMP4 has reported safety and pharmacokinetics data from single and multiple ascending dose cohorts in healthy volunteers.

CAMP4’s news flow includes financial and corporate updates such as private placements, underwritten offerings of common stock, and use of proceeds to support development of its product candidates. The company also reports on strategic agreements, including a research, collaboration and license agreement with GSK to discover and develop ASO drug candidates for neurodegenerative and kidney disease indications using CAMP4’s RAP Platform.

In addition, CAMP4 issues press releases on scientific presentations at major meetings, corporate highlights, and inducement grants under Nasdaq Listing Rule 5635(c)(4). Investors and observers can use this news page to review CAMP4’s reported milestones, research progress, and financing activities related to its regulatory RNA-targeting therapeutic strategy.

Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced that its Bus Guardian solution won the 2020 IoT Evolution Community Impact Award for effectively aiding schools during the COVID-19 pandemic. Developed by Synovia Solutions, Bus Guardian utilizes IoT technology to facilitate accurate contact tracing and hygiene verification for school buses, ensuring safer student transportation. CEO Jeff Gardner emphasized the importance of this technology for managing pandemic challenges. The award recognizes the solution's significant impact on community safety amid the pandemic.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.93%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
none
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) was awarded the 2020 OCTANe High Tech Award for Best Consumer Technology Innovation for its Here Comes The Bus® school bus tracking solution. This service is utilized by over 350 districts across North America, providing real-time notifications to more than 2 million users. The app has gained accolades for its innovative response during the pandemic, assisting with meal and homework deliveries. CEO Jeff Gardner emphasized the company's dedication to safety and innovation, marking the recognition as a significant achievement in a competitive consumer technology landscape.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.37%
Tags
none
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced a partnership between its subsidiary LoJack Italia and Maldarizzi Automotive to enhance vehicle safety for 12,000 customers in southern Italy. Vehicles sold by Maldarizzi will feature LoJack Connect, which offers real-time diagnostics and alerts for maintenance issues, improving overall road safety. The collaboration aims to provide timely crash response, maintenance reminders, and stolen vehicle assistance. This agreement was highlighted during the 'Automotive Dealer Day Digital Edition' webinar held on September 16-17, 2020, focusing on reducing traffic accidents in Italy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
none
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) has announced the release date for its fiscal 2021 second quarter results, set for September 24, 2020, after the market closes. Following this, a conference call will be held at 4:30 PM ET to discuss the financial results, accessible via the company's website. A replay of the call will be available for 90 days. With over 20 million products installed worldwide and 1.3 million software subscribers, CalAmp continues to be a pioneer in the mobile connected economy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.24%
Tags
conferences earnings
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced significant upgrades to its Synovia Solutions fleet intelligence platform, enhancing its mobile application capabilities. The new features allow fleet operators to clock in/out and conduct trip inspections remotely, addressing customer needs due to COVID-19. The upgrades aim to streamline operations and improve safety by incorporating COVID-19 hygiene checks and wellness validation. Synovia serves over 1,000 fleet customers and has achieved a user-friendly app rating of 4.7 stars on the Apple App Store, enhancing its value proposition in the mobile connected economy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.72%
Tags
covid-19
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.51%
Tags
none
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced the appointment of Kirsten Wolberg to its Board of Directors on August 26, 2020. Wolberg, currently serving as chief technology & operations officer at DocuSign, brings over 20 years of experience from companies like PayPal and Salesforce. Her expertise in technology management is seen as vital for CalAmp's corporate transformation and growth strategy. Both the Chair and CEO expressed confidence in her ability to contribute valuable insights to enhance shareholder value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.15%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.4%
Tags
none
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) appointed Amal M. Johnson as Chair of its Board of Directors, marking a significant leadership change as she replaces A.J. "Bert" Moyer. Johnson has served on the board for nearly seven years and is the first female Chair in the company's 39-year history. CEO Jeff Gardner expressed confidence in her ability to guide the company through growth and innovation, while Moyer commended her extensive experience in technology sectors. Johnson aims to drive continued growth and customer transformation in the mobile connected economy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
management

FAQ

What is the current stock price of Camp4 Therapeutics (CAMP)?

The current stock price of Camp4 Therapeutics (CAMP) is $6.275 as of March 9, 2026.

What is the market cap of Camp4 Therapeutics (CAMP)?

The market cap of Camp4 Therapeutics (CAMP) is approximately 217.9M.

CAMP Rankings

CAMP Stock Data

217.90M
42.94M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE

CAMP RSS Feed